Ceretype Neuromedicine is a next-generation fMRI brain biomarker platform to improve drug discovery and patient care in neuropsychiatry
Ceretype Neuromedicine has raised $100K in total funding. The most recent round was Pre-Seed. The last funding was announced in March 2023.
Ceretype Neuromedicine's investors include One Mind Accelerator, THE CATALYTIC IMPACT FOUNDATION (CIF), WPSS.bio, Leafy Tunnel, Cedar Street Group.
Ceretype Neuromedicine is headquartered in Cambridge, United States.
Ceretype Neuromedicine is a next-generation fMRI brain biomarker platform to improve drug discovery and patient care in neuropsychiatry
Ceretype Neuromedicine is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ceretype Neuromedicine — Funding & Investors." VCBacked, March 2, 2023, https://www.vcbacked.co/company/ceretype-neuromedicine. Accessed July 21, 2026.
VCBacked. (2023). Ceretype Neuromedicine — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/ceretype-neuromedicine
{{cite web |title=Ceretype Neuromedicine — Funding & Investors |url=https://www.vcbacked.co/company/ceretype-neuromedicine |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated